Introduction: Short and long sleep durations have been associated with adverse health outcomes. The objective of this study was to examine the association between self-reported sleep duration and chronic kidney disease (CKD) in the general population on the basis of the National Health and Nutrition Examination Survey (NHANES) database. Methods: A total of 28,239 adults aged ≥18 years who participated in the 2005–2014 NHANES were analyzed. CKD was defined as an estimated glomerular filtration rate <60 mL/min per 1.73 m2 or urinary albumin/urine creatinine ratio ≥300 mg/g. Very short sleepers and short sleepers were defined as those who sleep ≤5 h or 5.1–6.9 h per day, respectively. Long sleepers and very long sleepers were defined as those who sleep 9.0–10.9 h or ≥11 h per day, respectively. Normal sleepers were defined as those who sleep 7.0–8.9 h. The association between sleep duration and CKD was assessed using a logistic regression model. Results: Very short (≤5 h) sleep duration was associated with higher odds of CKD (multiadjusted OR, 1.38; 95% confidence interval, 1.17–1.62 comparing normal categories of 7.0–8.9 h; P trend = 0.01), after adjusting for potential confounders. Participants with long (9–10.9 h) sleep duration also tended to have a higher odds of CKD (multiadjusted OR, 1.39; 95% confidence interval, 1.20–1.61 comparing normal categories of 7.0–8.9 h; P trend = 0.01). This risk was further increased in those whose sleep duration exceeded 11 h (multiadjusted OR, 2.35; 95% confidence interval, 1.64–3.37 comparing normal categories of 7.0–8.9; P trend = 0.01). However, there was no statistically significant association between short (≤6.0–7.9 h) sleep duration and CKD (multiadjusted OR, 1.05; 95% confidence interval, 0.96–1.14 comparing normal categories of 7.0–8.9 h; P trend = 0.32). Conclusion: We demonstrated that the higher CKD prevalence estimates were found in very short (≤5 h) and long (9.0–10.9 h) sleep durations in an apparently healthy population aged ≥18 years in the USA. This prevalence of CKD is further increased in those whose sleep duration exceeds 11 h. Our cross-sectional analyses clarified the U-shaped temporal relationship between sleep duration and CKD.

1.
Levey
AS
,
Atkins
R
,
Coresh
J
,
Cohen
EP
,
Collins
AJ
,
Eckardt
KU
.
Chronic kidney disease as a global public health problem: approaches and initiatives: a position statement from Kidney Disease Improving Global Outcomes
.
Kidney Int
.
2007
;
72
(
3
):
247
59
.
2.
Oppelaar
JJ
,
Vogt
L
.
Body fluid-independent effects of dietary salt consumption in chronic kidney disease
.
Nutrients
.
2019
;
11
(
11
):
2779
.
3.
Burns
RB
,
Waikar
SS
,
Wachterman
MW
,
Kanjee
Z
.
Management options for an older adult with advanced chronic kidney disease and dementia: grand rounds discussion from beth Israel deaconess medical center
.
Ann Intern Med
.
2020
;
173
(
3
):
217
25
.
4.
Nigam
G
,
Camacho
M
,
Chang
ET
,
Riaz
M
.
Exploring sleep disorders in patients with chronic kidney disease
.
Nat Sci Sleep
.
2018
;
10
:
35
43
.
5.
ZamarróN
E
,
Jaureguizar
A
,
GarcíA-SáNCHEZ
A
,
Díaz-Cambriles
T
,
Alonso-Fernández
A
,
Lores
V
.
Obstructive sleep apnea is associated with impaired renal function in patients with diabetic kidney disease
.
Sci Rep
.
2021
;
11
(
1
):
5675
.
6.
Lo
K
,
Huang
YQ
,
Liu
L
,
Yu
YL
,
Chen
CL
,
Huang
JY
.
Serum vitamin D, sleep pattern and cardiometabolic diseases: findings from the national health and nutrition examination survey
.
Diabetes Metab Syndr Obes
.
2020
;
13
:
1661
8
.
7.
Ricardo
AC
,
Knutson
K
,
Chen
J
,
Appel
LJ
,
Bazzano
L
,
Carmona-Powell
E
.
The association of sleep duration and quality with CKD progression
.
J Am Soc Nephrol
.
2017
;
28
(
12
):
3708
15
.
8.
Ricardo
AC
,
Goh
V
,
Chen
J
,
Cedillo-Couvert
E
,
Kapella
M
,
Prasad
B
.
Association of sleep duration, symptoms, and disorders with mortality in adults with chronic kidney disease
.
Kidney Int Rep
.
2017
;
2
(
5
):
866
73
.
9.
Levey
AS
,
Stevens
LA
,
Schmid
CH
,
Zhang
YL
,
Castro
AF
3rd
,
Feldman
HI
.
A new equation to estimate glomerular filtration rate
.
Ann Intern Med
.
2009
;
150
(
9
):
604
12
.
10.
Levin
A
,
Stevens
PE
.
Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward
.
Kidney Int
.
2014
;
85
(
1
):
49
61
.
11.
Lee
HJ
,
Kwak
N
,
Kim
YC
,
Choi
SM
,
Lee
J
,
Park
YS
.
Impact of sleep duration on mortality and quality of life in chronic kidney disease: results from the 2007–2015 KNHANES
.
Am J Nephrol
.
2021
;
52
(
5
):
396
403
.
12.
Park
S
,
Lee
S
,
Kim
Y
,
Lee
Y
,
Kang
MW
,
Kim
K
.
Short or long sleep duration and CKD: a mendelian randomization study
.
J Am Soc Nephrol
.
2020
;
31
(
12
):
2937
47
.
13.
Li
J
,
Huang
Z
,
Hou
J
,
Sawyer
AM
,
Wu
Z
,
Cai
J
.
Sleep and CKD in Chinese adults: a cross-sectional study
.
Clin J Am Soc Nephrol
.
2017
;
12
(
6
):
885
92
.
14.
Nakajima
H
,
Hashimoto
Y
,
Okamura
T
,
Obora
A
,
Kojima
T
,
Hamaguchi
M
.
Association between sleep duration and incident chronic kidney disease: a population-based cohort analysis of the NAGALA study
.
Kidney Blood Press Res
.
2020
;
45
(
2
):
339
49
.
15.
Futrakul
N
,
Sridama
V
,
Futrakul
P
.
Microalbuminuria-a biomarker of renal microvascular disease
.
Ren Fail
.
2009
;
31
(
2
):
140
3
.
16.
Neumann
J
,
Ligtenberg
G
,
Klein
II
,
Koomans
HA
,
Blankestijn
PJ
.
Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment
.
Kidney Int
.
2004
;
65
(
5
):
1568
76
.
17.
Cappuccio
FP
,
Cooper
D
,
D’Elia
L
,
Strazzullo
P
,
Miller
MA
.
Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies
.
Eur Heart J
.
2011
;
32
(
12
):
1484
92
.
You do not currently have access to this content.